Beijing HyperStrong Technology
688411
Yalian Machinery
001395
Merit Interactive
300766
Pansoft
300996
Sublime China Information
301299
CN Stock MarketDetailed Quotes
300858 Beijing Scitop Bio-tech
- 13.60
- +0.05+0.37%
Market Closed Jan 27 15:00 CST
3.58BMarket Cap38.64P/E (TTM)
14.06High13.45Low52.95KlotVolume13.48Open13.55Pre Close72.57MTurnover2.73%Turnover Ratio38.31P/E (Static)263.50MShares19.9752wk High2.03P/B2.64BFloat Cap12.6652wk Low16.26Limit Up193.76MShs Float37.15Historical High10.84Limit Down4.50%Amplitude10.53Historical Low0.15Dividend TTM13.70Avg Price22.51KlotAsk1.10%Div YieldTTM100Lot Size28.53KlotBid
Beijing Scitop Bio-tech News
Ketuo Biotech: Announcement on changes in the equity of shareholders holding 5% or more of the shares reached 1%
Ketuo Biotech: Pre-disclosure Notice on Shareholders Holding 5% or More of Shares and Specific Shareholders Reducing Their Shareholdings
Beijing Scitop Bio-tech: Legal Opinion of Junzhi Law Firm Regarding the Adjustment of Grant Prices for Beijing Ketao Hengtong Biotechnology Co., Ltd.'s Restricted Stock Incentive Plan for the Year 2024.
Beijing Scitop Bio-tech: Announcement Regarding Adjustment of Grant Price of Restricted Stock Incentive Plan for 2024.
Beijing Scitop Bio-tech: Announcement of Annual Equity Distribution Implementation in 2023
Beijing Scitop Bio-tech: 2024 Restricted Stock Incentive Plan Incentive Recipients List (as of the first grant date)
Beijing Scitop Bio-tech: Verification opinion of the Supervisory Board on the list of persons eligible for the 2024 Restricted Stock Incentive Plan (as of the date of initial grant)
Beijing Scitop Bio-tech: Announcement on granting restricted shares to incentive recipients for the first time
Beijing Scitop Bio-tech: Legal Opinion of Beijing Junzhi Law Firm on matters relating to the first grant of the 2024 Restricted Stock Incentive Plan of Beijing Ketuo Hengtong Biotechnology Co., Ltd.
Cotuo Biotech: Simplified Equity Change Report (Zhang Liebing)
Cotuo Biotech: An indicative announcement on changes in shareholders' equity
Ketuo Biotech: Announcement on the expiration of the shareholders' holdings reduction plan
Cotuo Biotech: Announcement on the 2023 Profit Distribution Plan
Ketuo Biotech: Legal Opinion of Beijing Junzhi Law Firm on the Cancellation of the 2021 Restricted Stock Incentive Plan of Beijing Ketuo Hengtong Biotechnology Co., Ltd. and the granting of restricted shares not yet owned
Cotuo Biotech: Self-inspection report on the 2024 Restricted Stock Incentive Plan insider information and incentive targets trading the company's stock
Ketuo Biotech: Explanation of the Supervisory Board's Inspection Opinions and Publicity on the List of Incentive Targets for the Company's 2024 Restricted Stock Incentive Plan
Cotuo Biotech: Corrections to the 2024 Restricted Stock Incentive Plan (Draft) and its summary
Cotto Biotech: 2024 Restricted Stock Incentive Plan (Draft) Summary (Corrected)
Cotto Biotech: 2024 Restricted Stock Incentive Plan (Draft) (revised)
Ketuo Biotech: Legal Opinion of Beijing Junzhi Law Firm on the 2024 Restricted Stock Incentive Plan (Draft) of Beijing Ketuo Hengtong Biotechnology Co., Ltd.
